Daclatasvir and Sofosbuvir are direct-acting antiviral medicines used together in the treatment of chronic hepatitis C virus (HCV) infection. Because other medicines, supplements, and existing health conditions can affect treatment, patients should use this combination only under the supervision of a qualified healthcare professional.
What Are Daclatasvir and Sofosbuvir?
Daclatasvir is an HCV NS5A inhibitor, while Sofosbuvir is an HCV NS5B polymerase inhibitor. When used together, they target different stages of the hepatitis C virus life cycle.
A commonly supplied formulation contains Daclatasvir 60 mg and Sofosbuvir 400 mg tablets. The appropriate treatment regimen, duration, and need for additional medicines depend on factors such as HCV genotype, liver condition, previous treatment history, and current clinical guidelines.
Important Safety Information
Before starting Daclatasvir and Sofosbuvir, patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter products, vitamins, and herbal supplements.
Important safety considerations include:
- Follow the prescribed dose and treatment duration. Do not change or stop treatment without medical advice.
- Check for hepatitis B infection. Patients with current or previous hepatitis B infection may require monitoring because hepatitis B reactivation can occur during treatment with HCV direct-acting antivirals.
- Inform your doctor about liver disease. The treatment plan may require additional assessment in patients with advanced liver disease.
- Pregnancy considerations: If Daclatasvir and Sofosbuvir are prescribed with ribavirin, ribavirin has important pregnancy-related risks. Appropriate precautions and medical guidance are essential.
- Monitor other medicines: Some medicines can reduce antiviral exposure and potentially affect treatment effectiveness.
Common adverse effects reported with antiviral treatment may include headache, fatigue, nausea, or other gastrointestinal symptoms. Any severe, persistent, or unusual symptoms should be discussed promptly with a healthcare professional.
Daclatasvir Sofosbuvir Drug Interactions
Drug interactions are an important consideration when using Daclatasvir and Sofosbuvir. Certain medicines can change the amount of antiviral medicine in the body.
1. Strong Enzyme Inducers
Medicines that strongly induce drug-metabolizing enzymes or transport proteins may significantly reduce daclatasvir or sofosbuvir exposure. Examples include rifampicin, carbamazepine, phenytoin, and St. John’s wort. These combinations may reduce antiviral effectiveness and may need to be avoided.
2. HIV Medicines
Some antiretroviral medicines can interact with daclatasvir. Patients receiving HIV treatment should provide their complete medication list so that a healthcare professional can select an appropriate regimen and dose.
3. Heart Medicines
Patients taking amiodarone should tell their healthcare professional before using sofosbuvir-containing treatment. Serious symptomatic bradycardia has been reported when sofosbuvir-containing regimens are used with amiodarone, particularly when combined with other medicines that lower heart rate.
4. Other Prescription and OTC Medicines
Interactions can also involve medicines for seizures, infections, cardiovascular conditions, or other chronic diseases. Patients should not assume that a medicine is safe to combine simply because it is available without a prescription.
How Should Daclatasvir Sofosbuvir Be Taken?
Daclatasvir and Sofosbuvir should be taken exactly as prescribed. The tablets are generally taken orally, with or without food, according to the prescribed regimen.
Patients should avoid missing doses. If a dose is missed, the appropriate action depends on how much time has passed, so patients should follow the product information or contact their healthcare professional for advice.
Information for Buyers and Pharmaceutical Distributors
For pharmaceutical distributors, pharmacies, hospitals, and international buyers sourcing Daclatasvir 60 mg + Sofosbuvir 400 mg tablets, product selection should consider the manufacturer, formulation, packaging, batch information, storage requirements, regulatory status, and destination-country import requirements.
Global Pharma Trade can support enquiries for pharmaceutical products supplied from India, subject to applicable regulatory and import requirements.
Frequently Asked Questions
Can Daclatasvir and Sofosbuvir be taken with other medicines?
Some medicines can interact with this combination. A healthcare professional should review all prescription medicines, OTC products, and supplements before treatment.
Can patients take herbal supplements during treatment?
Patients should disclose all herbal products and supplements to their doctor or pharmacist because some, including St. John’s wort, can interact with antiviral medicines.
Is Daclatasvir Sofosbuvir prescription medicine?
Treatment with Daclatasvir and Sofosbuvir should be undertaken under appropriate medical supervision and according to the regulations applicable in the country of use.
What should buyers check when sourcing Daclatasvir Sofosbuvir?
Buyers should verify the active ingredients and strengths, manufacturer, packaging, batch details, product documentation, storage conditions, and destination-market regulatory requirements before purchasing.